PMC:7376974 / 785-1053
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T96517","span":{"begin":161,"end":166},"obj":"Body_part"}],"attributes":[{"id":"A93109","pred":"fma_id","subj":"T96517","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"14","span":{"begin":45,"end":61},"obj":"Disease"},{"id":"15","span":{"begin":63,"end":87},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"MESH:D001102"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":45,"end":61},"obj":"Disease"},{"id":"T8","span":{"begin":78,"end":87},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T82281","span":{"begin":161,"end":166},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T53798","span":{"begin":238,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":30,"end":35},"obj":"Chemical"},{"id":"T3","span":{"begin":256,"end":267},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T80802","span":{"begin":45,"end":61},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T18352","span":{"begin":209,"end":224},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":63,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ntially being next-generation drugs to fight viral infections. HNMs can block infection at early (disinfection, entrance inhibition) and middle (inside the host cells) stages and are also able to mitigate the immune response. This review is focused on the application "}